Hosted on MSN8m
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in IndiaTherapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback